A Dose of Reality and a Strategy for Risk
Of course, I can feel your skepticism, and it’s entirely justified. For every company that succeeds in these fields, dozens will likely fail spectacularly. They will burn through cash, hit technical brick walls, or simply be too early for their own good. Investing here is not like buying a blue-chip stock. It’s more like planting a forest. You know that not every sapling will grow into a mighty oak, and you accept that it will take a great deal of time and patience.
This is why a scattergun approach is, in my view, the only sensible one. You don’t bet the farm on a single idea. Instead, you look for ways to gain exposure to the entire landscape of innovation. This is precisely the thinking behind a collection like the New Moon Portfolio, which spreads its bets across several of these fledgling fields, from gene editing to AI diagnostics. The strategy is simple. By diversifying across multiple breakthrough technologies, the potential success of one could offset the inevitable failures of others. It’s a pragmatic way to approach a high-stakes game.
This isn’t about chasing guaranteed wins, because in investing, no such thing exists. It’s about positioning yourself for what could be. It requires a different mindset, one that values potential over proven performance and is comfortable with uncertainty. It’s a long game, but for those with the right temperament, it might just be the most interesting one in town.
